BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7543071)

  • 1. Granulocyte colony-stimulating factor (G-CSF) administration increases PMN CD32 (FcRII) expression and FcR-related functions.
    Carulli G; Minnucci S; Azzarà A; Angiolini C; Sbrana S; Caracciolo F; Ambrogi F
    Haematologica; 1995; 80(2):150-4. PubMed ID: 7543071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. fMLP-induced CD11b/CD18 upregulation on neutrophils from patients with non-Hodgkin's lymphomas treated with recombinant human granulocyte colony-stimulating factor.
    Carulli G; Azzarà A; Minnucci S; Angiolini C; Sbrana S; Ambrogi F
    J Exp Clin Cancer Res; 1997 Sep; 16(3):301-8. PubMed ID: 9387905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of recombinant human granulocyte colony-stimulating factor on neutrophil morphology, function and phenotype in patients with acute leukemia undergoing chemotherapy].
    Huang HH; Zhong JH; Han XF; Xuan ZH; Han JY; Chen FY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1033-7. PubMed ID: 16403274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the high-affinity receptor for IgG (FcRI, CD64) on neutrophils in multiple myeloma.
    Ohsaka A; Saionji K; Takagi S; Igari J
    Hematopathol Mol Hematol; 1996; 10(3):151-60. PubMed ID: 8878733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
    Pentheroudakis G; Malamou-Mitsi V; Briasoulis E; Damala K; Vassou A; Vartholomatos G; Kolaitis N; Pavlidis N
    Cancer; 2004 Oct; 101(8):1767-75. PubMed ID: 15386335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with granulocyte-colony-stimulating factor.
    Hubel K; Rodger E; Gaviria JM; Price TH; Dale DC; Liles WC
    Transfusion; 2005 Dec; 45(12):1876-89. PubMed ID: 16371040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma.
    Niitsu N; Hayama M; Okamoto M; Khori M; Higashihara M; Tamaru J; Hirano M
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4077-82. PubMed ID: 15217942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-CSF increases the number of peripheral blood dendritic cells CD16+ and modifies the expression of the costimulatory molecule CD86+.
    Talarn C; Urbano-Ispizua A; Martino R; Batlle M; Fernández-Avilés F; Herrera C; Pérez-Simón JA; Gaya A; Aymerich M; Pétriz J; Marín P; Sierra J; Montserrat E
    Bone Marrow Transplant; 2006 May; 37(9):873-9. PubMed ID: 16547488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally occurring and therapy-induced antibodies to human granulocyte colony-stimulating factor (G-CSF) in human serum.
    Laricchia-Robbio L; Moscato S; Genua A; Liberati AM; Revoltella RP
    J Cell Physiol; 1997 Nov; 173(2):219-26. PubMed ID: 9365526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
    Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
    Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peaks of endogenous G-CSF serum concentrations are followed by an increase in respiratory burst activity of granulocytes in patients with septic shock.
    Barth E; Fischer G; Schneider EM; Moldawer LL; Georgieff M; Weiss M
    Cytokine; 2002 Mar; 17(5):275-84. PubMed ID: 12027409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of granulocyte colony-stimulating factor on opsonin receptor expression in cerulein-induced acute pancreatitis.
    Tuo H; Sugiyama M; Nakashima M; Abe N; Watanabe T; Atomi Y
    Pancreas; 2005 Jan; 30(1):e16-21. PubMed ID: 15632691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S; Goldschmidt H; Ehrhardt R; Haas R
    Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
    Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
    Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rHuG-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell apheresis donors.
    Karadogan C; Karadogan I; Bilgin AU; Undar L
    Ther Apher Dial; 2006 Apr; 10(2):180-6. PubMed ID: 16684221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.
    Zucca A; Brizzi S; Riccioni R; Azzarà A; Ghimenti M; Carulli G
    Clin Ter; 2006; 157(1):19-24. PubMed ID: 16669548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil CD64 (FcgammaRI) expression is a specific marker of bacterial infection: a study on the kinetics and the impact of major surgery.
    Fjaertoft G; Håkansson LD; Pauksens K; Sisask G; Venge P
    Scand J Infect Dis; 2007; 39(6-7):525-35. PubMed ID: 17577814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
    Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
    Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.